Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Hepatitis

  Free Subscription


Articles published in Transplant Proc

Retrieve available abstracts of 77 articles:
HTML format



Single Articles


    May 2020
  1. CIECIURA T, Hryniewiecka E, Perkowska-Ptasinska A, Ciszek M, et al
    Shear Wave Elastography Performance in Noninvasive Assessment of Liver Cirrhosis in Liver Transplant Recipients With the Recurrence of Hepatitis C Infection.
    Transplant Proc. 2020 May 20. pii: S0041-1345(20)30094.
    PubMed     Abstract available


    March 2020
  2. CIECIURA T, Hryniewiecka E, Foroncewicz B, Strzelczyk Z, et al
    Long-Term Follow-up of Liver Transplant Recipients Treated With Direct-Acting Antiviral Agents for Hepatitis C Recurrence After Transplantation.
    Transplant Proc. 2020 Mar 30. pii: S0041-1345(19)31656.
    PubMed     Abstract available


  3. CIECIURA T, Urbanowicz A, Foroncewicz B, Hryniewiecka E, et al
    Hepatocellular Carcinoma Is a Negative Predictor of Sustained Viral Response in Liver Transplant Recipients With Hepatitis C Treated With Direct-Acting Antivirals.
    Transplant Proc. 2020 Mar 30. pii: S0041-1345(19)31659.
    PubMed     Abstract available


  4. RODRIGUES IC, Ferreira da Silva R, de Cassia Martins Alves da Silva R, Camarero de Felicio HC, et al
    Effectiveness Analysis of the Immunization Against Hepatitis B in Liver Transplantation Patients.
    Transplant Proc. 2020 Mar 18. pii: S0041-1345(19)31413.
    PubMed     Abstract available


  5. DEVRESSE A, Delire B, Lazarus JV, Kabamba B, et al
    Eliminating Hepatitis C Virus From a Prevalent Kidney Transplant Recipient Population: A Single-Center Study in Belgium in the Direct-Acting Antivirals Era.
    Transplant Proc. 2020 Mar 3. pii: S0041-1345(19)31337.
    PubMed     Abstract available


  6. DARSTEIN F, Hauser F, Mittler J, Zimmermann A, et al
    Hepatitis E Is a Rare Finding in Liver Transplant Patients With Chronic Elevated Liver Enzymes and Biopsy-Proven Acute Rejection.
    Transplant Proc. 2020 Mar 2. pii: S0041-1345(19)31006.
    PubMed     Abstract available


    February 2020
  7. MORENO-RAMIREZ M, Villanego F, Vigara LA, Cazorla JM, et al
    Direct-Acting Antiretroviral Therapy in Renal Transplant Recipients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection: Report of Our Experience and Literature Review.
    Transplant Proc. 2020 Feb 5. pii: S0041-1345(19)31131.
    PubMed     Abstract available


    January 2020
  8. EMORI CT, Uehara SNO, Amaral AC, Carvalho-Filho RJ, et al
    Observational Study Evaluating the Outcome of Cirrhotic Hepatitis C Patients Submitted to Renal Transplantation.
    Transplant Proc. 2020;52:89-96.
    PubMed     Abstract available


    December 2019
  9. BAYRAKTAR A, Akgul SU, Bakkaloglu H, Temurhan S, et al
    Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?
    Transplant Proc. 2019 Dec 31. pii: S0041-1345(19)30884.
    PubMed     Abstract available


    November 2019
  10. PETRINI C, Trapani S, Riva L, Floridia G, et al
    Organ Transplantation From Nonstandard Risk Donors: Midway Between Rigid and Flexible Rules.
    Transplant Proc. 2019;51:2856-2859.
    PubMed     Abstract available


    October 2019
  11. VALENTE G, Miglioresi L, Sgueglia T, Rinaldi L, et al
    Toward Zero Hepatitis C Virus-Related Mortality as a Prerequisite for the Release of Resources in a Center for Follow-up of Liver Transplant.
    Transplant Proc. 2019 Oct 16. pii: S0041-1345(19)30585.
    PubMed     Abstract available


    August 2019
  12. SERIN A, Tokat Y
    Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus-Related Chronic Liver Disease.
    Transplant Proc. 2019 Aug 9. pii: S0041-1345(18)31750.
    PubMed     Abstract available


  13. SERIN A, Sahin T, Emek E, Arikan T, et al
    Role of Preoperative Viral Load and Presence of Hepatocellular Carcinoma in the Biliary Complications After Liver Transplantation Due to Hepatitis C Virus.
    Transplant Proc. 2019 Aug 9. pii: S0041-1345(19)30242.
    PubMed     Abstract available


  14. SAHIN T, Serin A, Emek E, Bozkurt B, et al
    Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis.
    Transplant Proc. 2019 Aug 8. pii: S0041-1345(18)31711.
    PubMed     Abstract available


  15. SERIN A, Sahin T, Arikan BT, Emek E, et al
    A Changing Etiologic Scenario in Liver Transplantation: A Single-Center Cohort Study From Turkey.
    Transplant Proc. 2019 Aug 8. pii: S0041-1345(18)31712.
    PubMed     Abstract available


    July 2019
  16. MENG C, Liu T, Liu YW, Zhang LZ, et al
    Hepatitis B Virus cccDNA in Hepatocellular Carcinoma Tissue Increases the Risk of Recurrence After Liver Transplantation.
    Transplant Proc. 2019 Jul 26. pii: S0041-1345(19)30497.
    PubMed     Abstract available


  17. MOTOMURA T, Yoshizumi T, Kosai-Fujimoto Y, Mano Y, et al
    Adult T-Cell Leukemia After Deceased Donor Liver Transplantation for Acute Liver Failure: A Case Report.
    Transplant Proc. 2019 Jul 11. pii: S0041-1345(19)30315.
    PubMed     Abstract available


  18. SIDDIQUI MB, Patel S, Bhati C, Reichman T, et al
    Range of Normal Serum Aminotransferase Levels in Liver Transplant Recipients.
    Transplant Proc. 2019;51:1895-1901.
    PubMed     Abstract available


    May 2019
  19. DUNDAR HZ, Aksoy F, Aksoy SA, Tasar P, et al
    Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Transplant Proc. 2019;51:1157-1161.
    PubMed     Abstract available


    April 2019
  20. NUGROHO A, Lee KW, Kim H, Yi NJ, et al
    De Novo Hepatitis B Virus Infection After Liver Transplantation in Hepatitis B Core-positive Recipients Using Hepatitis B Core-negative Grafts.
    Transplant Proc. 2019;51:842-844.
    PubMed     Abstract available


  21. FAUST I, Weile J, Fujita B, Kandolf R, et al
    Heart Transplantation in Systemic Sclerosis: New Impulses for Conventional Scleroderma Transplantation Regimen and Scleroderma Diagnostic Monitoring: 2 Case Reports.
    Transplant Proc. 2019;51:865-870.
    PubMed     Abstract available


    March 2019
  22. SINGH D, Hassan M, Lim N
    Reactivation of Hepatitis B Virus Infection With Reverse Seroconversion Following Umbilical Cord Allogeneic Hematopoietic Cell Transplantation in a Hepatitis-B-Immune Patient: A Case Report.
    Transplant Proc. 2019;51:602-604.
    PubMed     Abstract available


  23. AMBROCIO GPL, Aguado S, Carrillo J, Laporta R, et al
    Hepatitis E Virus Infection in Lung Transplant Recipients: A Case Series.
    Transplant Proc. 2019;51:376-379.
    PubMed     Abstract available


    February 2019
  24. ACAR S, Gencdal G, Kirimlioglu H, Polat KY, et al
    Varicella-Zoster Virus-Induced Hepatitis in a Liver Transplant Recipient: A Case Report.
    Transplant Proc. 2019 Feb 8. pii: S0041-1345(18)31720.
    PubMed     Abstract available


    December 2018
  25. WONG TCL, Fung JYY, Chok KSH, Cheung TT, et al
    Hepatitis B Vaccination in Patients Receiving Oral Antiviral Therapy Without Hepatitis B Immunoglobulin After Liver Transplant.
    Transplant Proc. 2018;50:3681-3688.
    PubMed     Abstract available


  26. SUNDARAM V, Wu T, Klein AS, Noureddin M, et al
    Liver Transplantation for Severe Alcoholic Hepatitis: Report of a Single Center Pilot Program.
    Transplant Proc. 2018;50:3527-3532.
    PubMed     Abstract available


  27. NG C, Danguilan R, Pamugas G, Que E, et al
    Outcomes of Renal Allograft Recipients With Hepatitis B From January 2000 to December 2010.
    Transplant Proc. 2018;50:3242-3248.
    PubMed     Abstract available


    November 2018
  28. JUNG BH, Park JI, Lee SG
    Successful Treatment of Fibrosing Cholestatic Hepatitis With Daclatasvir and Asunaprevir After Liver Transplantation: A Case Report.
    Transplant Proc. 2018;50:2877-2881.
    PubMed     Abstract available


  29. HUANG TL, Chen TY, Tsang LC, Ou HY, et al
    Acoustic Radiation Force Impulse Elastography in Post-transplant Recurrent Hepatitis C in Living Donor Liver Transplantation.
    Transplant Proc. 2018;50:2695-2698.
    PubMed     Abstract available


  30. LIN LM, Kuo SC, Chiu YC, Lin HF, et al
    Cost Analysis and Determinants of Living Donor Liver Transplantation in Taiwan.
    Transplant Proc. 2018;50:2601-2605.
    PubMed     Abstract available


    September 2018
  31. WOJTOWICZ M, Wilkowski P, Hryniewiecka E, Cieciura T, et al
    Effect of Successful Treatment of Hepatitis C Virus Infection Recurrence With Direct-Acting Antiviral Agents on Physical Performance in Liver Transplant Recipients.
    Transplant Proc. 2018;50:2027-2030.
    PubMed     Abstract available


    July 2018
  32. PLISZCZYNSKI J, Jasztal K, Jozwik A, Kosieradzki M, et al
    Results of Renal Transplant From Deceased Anti-hepatitis C Virus Donors, Poland 1998-2012.
    Transplant Proc. 2018;50:1691-1696.
    PubMed     Abstract available


  33. WAZNA E, Pazik J, Perkowska-Ptasinska A, Durlik M, et al
    Does Histopathology of Implanted Kidney According to Banff 07 Help Predict Long-term Transplantation Outcome?
    Transplant Proc. 2018;50:1765-1768.
    PubMed     Abstract available


    June 2018
  34. GARCIA-PAJARES F, Tejedor-Tejada J, Torres-Yuste R, Almohalla-Alvarez C, et al
    Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30877.
    PubMed     Abstract available


  35. RAYA AM
    Influence of Donor Obesity on Long-Term Liver Transplantation Outcomes.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30837.
    PubMed     Abstract available


  36. KWON JH, Hanouneh IA, Allende D, Yerian L, et al
    De Novo Autoimmune Hepatitis Following Liver Transplantation.
    Transplant Proc. 2018;50:1451-1456.
    PubMed     Abstract available


  37. PESCHEL G, Moleda L, Baier L, Selgrad M, et al
    Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post-Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response-A Single-Center Study.
    Transplant Proc. 2018;50:1444-1450.
    PubMed     Abstract available


  38. BODRO M, Sanclemente G, Crespo G, Linares L, et al
    Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients.
    Transplant Proc. 2018;50:1437-1443.
    PubMed     Abstract available


  39. WAHAB MA, Shehta A, Elshoubary M, Yassen AM, et al
    Living-Donor Liver Transplantation in Hepatitis C Virus Era: A Report of 500 Consecutive Cases in a Single Center.
    Transplant Proc. 2018;50:1396-1406.
    PubMed     Abstract available


    April 2018
  40. IMAI H, Kamei H, Onishi Y, Ishizu Y, et al
    Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus.
    Transplant Proc. 2018 Apr 25. pii: S0041-1345(18)30211.
    PubMed     Abstract available


  41. ORUC A, Ersoy A
    Transplantation Opportunities of Hepatitis C Virus-Seropositive Patients on the Kidney Waiting List.
    Transplant Proc. 2018 Apr 18. pii: S0041-1345(18)30614.
    PubMed     Abstract available


  42. TAKEUCHI S, Takamura M, Yoshida T, Takahashi K, et al
    Ombitasvir-Paritaprevir-Ritonavir Therapy in a Kidney Transplant Recipient With Chronic Hepatitis C Virus Genotype 1 Infection: A Case Report on the Importance of Considering Drug-Drug Interactions and Monitoring Cyclosporine Levels.
    Transplant Proc. 2018;50:884-886.
    PubMed     Abstract available


  43. WEIGERT A, Querido S, Carvalho L, Lebre L, et al
    Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal.
    Transplant Proc. 2018;50:743-745.
    PubMed     Abstract available


  44. MUCENIC M, Bandeira de Mello Brandao A, Marroni CA, Medeiros Fleck A Jr., et al
    Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World Study.
    Transplant Proc. 2018;50:769-771.
    PubMed     Abstract available


  45. MARTINO RB, Waisberg DR, Dias APM, Inoue VBS, et al
    Stratifying Mortality in a Model for End-Stage Liver Disease Waiting List: A Brazilian Single-Center Study.
    Transplant Proc. 2018;50:758-761.
    PubMed     Abstract available


    March 2018
  46. TENORIO GONZALEZ E, Robles Diaz M, Sanjuan Jimenez R, Gonzalez Grande R, et al
    Retransplant Due to Fulminant Hepatic Failure From Hepatitis E Virus: A Case Report.
    Transplant Proc. 2018;50:685-686.
    PubMed     Abstract available


  47. NOGUERAS LOPEZ F, Lopez Garrido A, Ortega Suazo EJ, Vadillo Calles F, et al
    Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients.
    Transplant Proc. 2018;50:631-633.
    PubMed     Abstract available


  48. CAICEDO LA, Delgado A, Garcia VH, Aristizabal AM, et al
    Liver Transplantation in Hepatitis C-Infected Patients: Experience From a South American Transplant Center.
    Transplant Proc. 2018;50:493-498.
    PubMed     Abstract available


    January 2018
  49. MIUMA S, Miyaaki H, Miyazoe Y, Suehiro T, et al
    Development of Duodenal Ulcers due to the Discontinuation of Proton Pump Inhibitors After the Induction of Sofosbuvir Plus Ledipasvir Therapy: A Report of Two Cases.
    Transplant Proc. 2018;50:222-225.
    PubMed     Abstract available


    December 2017
  50. MOTOMURA T, Yoshizumi T, Ohira M, Mano Y, et al
    Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:2409-2410.
    PubMed     Abstract available


    November 2017
  51. TOWNSEND SA, Monga MA, Nightingale P, Mutimer D, et al
    Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
    Transplant Proc. 2017;49:2129-2134.
    PubMed     Abstract available


  52. ROULLET S, Defaye M, Quinart A, Adam JP, et al
    Liver Transplantation With Old Grafts: A Ten-Year Experience.
    Transplant Proc. 2017;49:2135-2143.
    PubMed     Abstract available


    October 2017
  53. FREY A, Ecker EM, Piras-Straub K, Walker A, et al
    Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
    Transplant Proc. 2017;49:1947-1955.
    PubMed     Abstract available


  54. LIAO HT, Tan P, Huang JW, Yuan KF, et al
    Ledipasvir + Sofosbuvir for Liver Transplant Recipients With Recurrent Hepatitis C: A Systematic Review and Meta-analysis.
    Transplant Proc. 2017;49:1855-1863.
    PubMed     Abstract available


    September 2017
  55. SHAFII AE, Harris DD 2nd, Baz M
    Clearance of Hepatitis C Virus Prior to Lung Transplantation: A Case Report.
    Transplant Proc. 2017;49:1682-1684.
    PubMed     Abstract available


  56. NAKANO R, Ohira M, Ishiyama K, Ide K, et al
    Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:1634-1638.
    PubMed     Abstract available


    July 2017
  57. TRONINA O, Slubowska K, Mikolajczyk-Korniak N, Komuda-Leszek E, et al
    Fibrosing Cholestatic Hepatitis C After Liver Transplantation: Therapeutic Options Before and After Introduction of Direct-Acting Antivirals: Our Experience and Literature Review.
    Transplant Proc. 2017;49:1409-1418.
    PubMed     Abstract available


    June 2017
  58. OHIRA M, Nishida S, Tryphonopoulos P, Ruiz P, et al
    Impact of Steroids on Natural Killer Cells Against Cytotoxicity and Hepatitis C Virus Replication.
    Transplant Proc. 2017;49:1160-1164.
    PubMed     Abstract available


  59. CHO CW, Kwon CHD, Kim JM, Choi GS, et al
    Comparative Analysis of the Clinical Outcomes of Liver Transplantation for Probable and Definite Auto-immune Hepatitis by International Diagnostic Scoring Criteria.
    Transplant Proc. 2017;49:1126-1128.
    PubMed     Abstract available


  60. KOSHINO K, Ushigome H, Masuda K, Matsuyama T, et al
    Effective Treatment With Daclatasvir and Asunaprevir in Kidney Transplant Patients Infected With Hepatitis C Virus: A Report of Two Cases.
    Transplant Proc. 2017;49:1053-1055.
    PubMed     Abstract available


  61. YU YD, Kim DS, Han JH, Yoon YI, et al
    Successful Treatment of a Patient With Diffuse Portosplenomesenteric Thrombosis Using a Pericholedochal Varix for Portal Flow Reconstruction During Deceased Donor Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:1202-1206.
    PubMed     Abstract available


    May 2017
  62. PIAI G, Miglioresi L, Valente G
    Eradication of Hepatitis C After Liver Transplantion: Consequences for the Organization of the Transplant Patient's Follow-up.
    Transplant Proc. 2017;49:671-673.
    PubMed     Abstract available


  63. TRAPANI S, Rizzato L, Masiero L, Ricci A, et al
    Hepatitis C Virus Positive Patients on the Waiting List for Liver Transplantation: Turnover and Characteristics of the Population on the Eve of the Therapeutic Revolution With Direct-Acting Antivirals.
    Transplant Proc. 2017;49:658-666.
    PubMed     Abstract available


    April 2017
  64. ULKU A, Akcam AT, Rencuzogullari A, Dalci K, et al
    Effect of Dosage and Type of Hepatitis B Immunoglobulin on Hepatitis Antibody Levels in Liver Transplant Recipients.
    Transplant Proc. 2017;49:575-579.
    PubMed     Abstract available


    January 2017
  65. MELLO F, Girao C, Castro CC, Fiuza S, et al
    De Mello's Single Incision for Combined Liver-kidney Transplantation, Keeping the Kidney Retroperitoneal: A Case Report.
    Transplant Proc. 2017;49:169-171.
    PubMed     Abstract available


    November 2016
  66. CHOI S, Kim KK, Lee WS, Kang JM, et al
    Living Donor Liver Transplantation in a Patient With Extensive Portomesenteric Venous Thrombosis: Case Report.
    Transplant Proc. 2016;48:3153-3155.
    PubMed     Abstract available


  67. GARCIA BERNARDO CM, Arguelles Garcia B, Redondo Buil P, Miyar de Leon A, et al
    Collateral Development in Thrombosis of the Hepatic Artery After Transplantation.
    Transplant Proc. 2016;48:3006-3009.
    PubMed     Abstract available


  68. SAFWAN M, Nagai S, Abouljoud MS
    Portal Vein Inflow From Enlarged Coronary Vein in Liver Transplantation: Surgical Approach and Technical Tips: A Case Report.
    Transplant Proc. 2016;48:3070-3072.
    PubMed     Abstract available


  69. CEPEDA-FRANCO C, Bernal-Bellido C, Barrera-Pulido L, Alamo-Martinez JM, et al
    Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
    Transplant Proc. 2016;48:2983-2986.
    PubMed     Abstract available


    October 2016
  70. ALDEMIR E, Coskunol H, Kilic M, Sert I, et al
    Treatment of Opioid Dependence With Buprenorphine/Naloxone After Liver Transplantation: Report of Two Cases.
    Transplant Proc. 2016;48:2769-2772.
    PubMed     Abstract available


    September 2016
  71. BENITEZ-GUTIERREZ L, de Mendoza C, Banos I, Duca A, et al
    Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir.
    Transplant Proc. 2016;48:2515-2518.
    PubMed     Abstract available


  72. TEIXEIRA HR, Marques DM, Lopes AR, Ziviani LC, et al
    Anxiety and Stress Levels on Liver Transplantation Candidates.
    Transplant Proc. 2016;48:2333-2337.
    PubMed     Abstract available


  73. MONTE DA SILVA AG, deA Roza Aguiar B, Chiavegato LD
    Association Between Dyspnea and Severity of Liver Disease in Patients in the Pre-transplantation Period-A Pilot Study.
    Transplant Proc. 2016;48:2328-2332.
    PubMed     Abstract available


  74. DE FELICIO HC, da Silva RC, da Costa AM, Arroyo PC Jr, et al
    Family Members, Transplantation Candidates, and Patients Who Underwent Liver Transplantation Had Insufficient Information About the Procedure.
    Transplant Proc. 2016;48:2323-2327.
    PubMed     Abstract available


    June 2016
  75. WASIAK D, Jonas M, Lagiewska B, Cieciura T, et al
    Delayed, Uncommon Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Case Report.
    Transplant Proc. 2016;48:1855-7.
    PubMed     Abstract available


  76. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Transplant Registry in Poland: Web-Netted Quality Tool in Liver Transplantation From Deceased and Living Donors.
    Transplant Proc. 2016;48:1347-9.
    PubMed     Abstract available


  77. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Donation and Transplantation in Poland: Numbers, Indicators, and Trends.
    Transplant Proc. 2016;48:1341-6.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: